Leadership Overview
Amneal Pharmaceuticals has 5 executives leading key functions including global quality compliance, human resources, strategic operations, information technology, and regional management.
Driven by a commitment to accessible healthcare, Amneal Pharmaceuticals delivers essential medicines through a robust global infrastructure. The organization prioritizes scientific rigor and innovation to address complex medical needs while expanding market reach.
Driven by a commitment to accessible healthcare, Amneal Pharmaceuticals delivers essential medicines through a robust global infrastructure. The organization prioritizes scientific rigor and innovation to address complex medical needs while expanding market reach.
Leadership Roles at Amneal Pharmaceuticals
Hiral Kuvadia - Chief of Staff & Strategic To Partner & President
Hiral Kuvadia, the Chief of Staff & Strategic To Partner & President at Amneal Pharmaceuticals, manages the execution of high-level corporate initiatives and cross-functional projects. Overseeing the alignment of strategic goals, Kuvadia ensures that the executive office functions with precision to support the company mission of delivering essential medicines. This role involves facilitating communication between departments to streamline decision-making processes and accelerate the delivery of complex products. By monitoring key performance indicators, Hiral Kuvadia provides actionable insights that guide the leadership team in navigating market challenges. Kuvadia also coordinates with regional heads to ensure that strategic investments in production and commercial infrastructure yield maximum impact. Through the management of critical business operations, Kuvadia supports the overall growth strategy, ensuring that the organization remains focused on providing accessible and affordable healthcare solutions to patients across various global markets.
Sanjay Jain - President, Amneal (India)
Sanjay Jain, the President, Amneal (India) at Amneal Pharmaceuticals, oversees the strategic operations and manufacturing footprint within the Indian market. Directing the expansion of production capabilities, Jain ensures that the regional business contributes effectively to the global portfolio of generics and branded medicines. This role involves managing local commercial infrastructure and ensuring that all operations align with the high standards of scientific rigor established by the company. By optimizing regional supply chains, Sanjay Jain facilitates the delivery of essential medicines to both domestic and international markets. Jain collaborates with global leadership to integrate Indian operations into the broader corporate strategy, focusing on efficiency and innovation. Through the management of regional talent and resources, Jain supports the company mission of making quality healthcare more accessible. This leadership role drives the growth of the organization by leveraging the unique manufacturing and research advantages present in the region.
Jatin Savani - Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE)
Jatin Savani, the Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE) at Amneal Pharmaceuticals, directs comprehensive quality assurance protocols across all manufacturing sites. Overseeing global compliance frameworks, Savani ensures adherence to stringent regulatory standards for essential medicines. This leadership role involves managing supplier quality and external manufacturing partnerships to maintain supply chain integrity. By aligning marketing strategies with quality outcomes, Savani drives brand trust within the pharmaceutical sector. Jatin Savani also coordinates with the executive team to optimize production capabilities, ensuring that high-quality products reach diverse international markets efficiently. Through rigorous oversight of quality management systems, Savani mitigates operational risks and supports the broader mission of delivering affordable healthcare solutions. This focus on excellence reinforces the company position as a leader in the global generics and branded medicine landscape.
Nikita Shah - Executive VP & Chief Human Resources Officer
Nikita Shah, the Executive VP & Chief Human Resources Officer at Amneal Pharmaceuticals, architects the organizational culture and talent development strategies necessary for a global pharmaceutical enterprise. Overseeing human capital initiatives, Shah ensures that leadership development and employee well-being programs remain central to the company growth trajectory. This role involves designing recruitment and retention frameworks that attract top scientific and commercial talent to support the expanding portfolio of biosimilars and injectables. By fostering an inclusive and high-performance environment, Nikita Shah directly impacts the operational efficiency of the workforce. Shah collaborates with other C-suite leaders to align human resources policies with long-term business objectives, ensuring that the organization maintains the agility required for rapid market expansion. Through strategic workforce planning, Shah secures the human infrastructure needed to deliver innovation and maintain the competitive edge of the company in the evolving healthcare industry.
Kanda Natarajan - Senior VP, Chief Information Officer
Kanda Natarajan, the Senior VP, Chief Information Officer at Amneal Pharmaceuticals, directs the digital transformation and information technology strategy for the entire global organization. Overseeing the implementation of advanced data systems, Natarajan ensures that the company maintains robust production capabilities and secure commercial infrastructure. This role involves managing the technological backbone that supports scientific research, supply chain logistics, and regulatory compliance. By integrating innovative digital solutions, Kanda Natarajan enhances operational efficiency and data-driven decision-making across all business units. Natarajan collaborates with the executive team to align IT investments with the broader goal of delivering affordable access to essential medicines. Through the modernization of enterprise systems, Natarajan supports the company ability to scale operations and meet the demands of tomorrows health challenges. This leadership role remains vital for maintaining the technological agility required to compete in the global pharmaceutical market.
Explore Leadership Teams in Manufacturing
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.
Company Leadership AM
LP
RV
CF
Eisai is a global pharmaceutical manufacturing company founded in 1941. The company develops and produces medicines while focusing on a human health care approach that extends beyond traditional pharmaceutical services. Eisai operates across multiple regions including North America, Europe, Asia Pacific, and the Middle East, with a strong presence in countries such as the United States, Japan, China, and the United Kingdom. The company maintains a significant focus on research and development in the pharmaceutical sector, with particular emphasis on patient-centered healthcare solutions. Eisai's business model encompasses both business-to-business and business-to-consumer operations, reflecting its comprehensive approach to healthcare delivery and pharmaceutical development.
Company Leadership


SP
Bausch & Lomb is a global eye health company that develops, manufactures and markets healthcare products. The company's products include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. They are based in Vaughan, Ontario, Canada.
Company Leadership JY
AG
JF
KG
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally administered, small molecule drugs that target post-transcriptional control processes. The companys lead product is Translarna (ataluren), for the treatment of nonsense mutation Duchenne muscular dystrophy in ambulatory patients. The company is headquartered in South Plainfield, New Jersey.
Company Leadership LB
DM
